BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis
Faith Jessica Paran, Rieko Oyama, Abdullah Khasawneh, Tomohiko Ai, Hendra Saputra Ismanto, A. A. Sherif, Dianita S. Saputri, Chikako Ono, Mizue Saita, Satomi Takei, Yuki Horiuchi, Ken Yagi, Yoshiharu Matsuura, Yasushi Okazaki, Kazuhisa Takahashi, , Toshio Naito
This study finds that BCR repertoire diversity, not TCR diversity, correlates with favorable outcomes in COVID-19 patients.
Frontiers in Immunology · Oct 28, 2024Peer-reviewedImmunology